Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
After finishing at $24.45 in the prior trading day, Phibro Animal Health Corp (NASDAQ: PAHC) closed at $23.96, down -2.00%. In other words, the price has decreased by -$2.00 from its previous closing price. On the day, 0.22 million shares were traded. PAHC stock price reached its highest trading level at $24.48 during the session, while it also had its lowest trading level at $23.94.
Ratios:
Our goal is to gain a better understanding of PAHC by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 13.81 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 19.80. For the most recent quarter (mrq), Quick Ratio is recorded 1.23 and its Current Ratio is at 2.91. In the meantime, Its Debt-to-Equity ratio is 2.89 whereas as Long-Term Debt/Eq ratio is at 2.80.
On September 10, 2024, JP Morgan started tracking the stock assigning a Neutral rating and target price of $22.
On December 07, 2023, Exane BNP Paribas started tracking the stock assigning a Underperform rating and target price of $9.Exane BNP Paribas initiated its Underperform rating on December 07, 2023, with a $9 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 19 ’25 when BFI Co., LLC bought 241,129 shares for $24.00 per share.
CORCORAN E THOMAS bought 5,000 shares of PAHC for $110,500 on Feb 24 ’25. The Director now owns 30,000 shares after completing the transaction at $22.10 per share. On Feb 18 ’25, another insider, BFI Co., LLC, who serves as the 10% Owner of the company, bought 247,769 shares for $25.77 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PAHC now has a Market Capitalization of 991047872 and an Enterprise Value of 1666154240. As of this moment, Phibro’s Price-to-Earnings (P/E) ratio for their current fiscal year is 30.66, and their Forward P/E ratio for the next fiscal year is 10.65. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.07. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.82 while its Price-to-Book (P/B) ratio in mrq is 3.65. Its current Enterprise Value per Revenue stands at 1.399 whereas that against EBITDA is 10.687.
Stock Price History:
The Beta on a monthly basis for PAHC is 0.74, which has changed by 0.35062003 over the last 52 weeks, in comparison to a change of 0.092761636 over the same period for the S&P500. Over the past 52 weeks, PAHC has reached a high of $26.55, while it has fallen to a 52-week low of $16.16. The 50-Day Moving Average of the stock is 11.35%, while the 200-Day Moving Average is calculated to be 7.75%.
Shares Statistics:
The stock has traded on average 234.06K shares per day over the past 3-months and 202680 shares per day over the last 10 days, according to various share statistics. A total of 20.37M shares are outstanding, with a floating share count of 20.22M. Insiders hold about 50.12% of the company’s shares, while institutions hold 50.28% stake in the company. Shares short for PAHC as of 1748563200 were 907431 with a Short Ratio of 3.88, compared to 1745971200 on 912469. Therefore, it implies a Short% of Shares Outstanding of 907431 and a Short% of Float of 6.280000500000001.
Dividends & Splits
In the trailing 12 months, PAHC’s forward annual dividend rate was 0.48, compared to 0.48 this year. Against a Trailing Annual Dividend Yield of 0.0196319The stock’s 5-year Average Dividend Yield is 2.75.
